Share price increased from $32 to $34 per share.
Eli Lilly and Company reached an agreement with ICOS to amend the merger agreement relating to the proposed acquisition of ICOS by Lilly. Under the revised terms, Lilly will acquire all of the outstanding shares of ICOS common stock at a price of $34 per share, for a total purchase price of approximately $2.3 billion.
he proposed $34 price reflects a $2 per share increase from the $32 per share of the original merger agreement, and Lilly is affirming that this is its best and final offer.
